Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Thiel, Jens ^a   Hässler, Fabian ^a   Salzer, Ulrich ^a   Voll, Reinhard E ^a   Venhoff, Nils ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RITUXIMAB; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; B LYMPHOCYTE; BLOOD CHEMISTRY; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIC GRANULOMA; EOSINOPHILIC GRANULOMA WITH POLYANGIITIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE SUBPOPULATION; MALE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RELAPSE; REMISSION; RESPIRATORY TRACT INFECTION; SEMINOMA; SENSITIVITY AND SPECIFICITY; SERUM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; BLOOD; DRUG EFFECT; DRUG RESISTANCE; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; TIME;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; B-LYMPHOCYTE SUBSETS; C-REACTIVE PROTEIN; CHURG-STRAUSS SYNDROME; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884550922     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4313     Document Type: Article

References (32)

1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951, 27:277-301. 1937314, 14819261.
2. Vaglio A, Buzio C, Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art. Allergy 2013, 68:261-273. 10.1111/all.12088, 23330816.
3. Moosig F, Bremer JP, Hellmich B, Holle JU, Holl-Ulrich K, Laudien M, Matthis C, Metzler C, Nölle B, Richardt G, Gross WL. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis 2013, 72:1011-1017. 10.1136/annrheumdis-2012-201531, 22887848.
4. Comarmond C, Pagnoux C, Khellaf M, Cordier J-F, Hamidou M, Viallard J-F, Maurier F, Jouneau S, Bienvenu B, Puéchal X, Aumaitre O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogué B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L, French Vasculitis Study Group Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013, 65:270-281. 10.1002/art.37721, 23044708, French Vasculitis Study Group.
5. Müschen M, Warskulat U, Perniok A, Even J, Moers C, Kismet B, Temizkan N, Simon D, Schneider M, Häussinger D. Involvement of soluble CD95 in Churg-Strauss syndrome. Am J Pathol 1999, 155:915-925. 10.1016/S0002-9440(10)65191-7, 1866905, 10487849.
6. Kiene M, Csernok E, Müller A, Metzler C, Trabandt A, Gross WL. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum 2001, 44:469-473. 10.1002/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0, 11229479.
7. Campbell HD, Tucker WQ, Hort Y, Martinson ME, Mayo G, Clutterbuck EJ, Sanderson CJ, Young IG. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc Natl Acad Sci USA 1987, 84:6629-6633. 10.1073/pnas.84.19.6629, 299136, 3498940.
8. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994, 179:881-887. 10.1084/jem.179.3.881, 2191401, 7509365.
9. Samson M, Puéchal X, Devilliers H, Ribi C, Cohen P, Stern M, Pagnoux C, Mouthon L, Guillevin L, Group FVS. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials. J Autoimmun 2013, 43:60-69.
10. Kaushik VV, Reddy HV, Bucknall RC. Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome. Ann Rheum Dis 2006, 65:1116-1117. 10.1136/ard.2005.047308, 1798243, 16837496.
11. Dønvik KK, Omdal R. Churg-Strauss syndrome successfully treated with rituximab. Rheumatol Int 2010, 31:89-91.
12. Saech J, Owczarczyk K, Owczarzyk K, Rösgen S, Petereit H, Hallek M, Rubbert-Roth A. Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement. Ann Rheum Dis 2010, 69:1254-1255.
13. Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Russo A, Menegatti E, Baldovino S. Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. Am J Nephrol 2011, 34:175-180. 10.1159/000329535, 21757891.
14. Koukoulaki M, Smith KGC, Jayne DRW. Rituximab in Churg-Strauss syndrome. Ann Rheum Dis 2006, 65:557-559. 10.1136/ard.2005.042937, 1798092, 16531558.
15. Cartin-Ceba R, Keogh KA, Specks U, Sethi S, Fervenza FC. Rituximab for the treatment of Churg-Strauss syndrome with renal involvement. Nephrol Dial Transplant 2011, 26:2865-2871. 10.1093/ndt/gfq852, 3218640, 21325353.
16. Pepper RJ, Fabre MA, Pavesio C, Gaskin G, Jones RB, Jayne D, Pusey CD, Salama AD. Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatology (Oxford) 2008, 47:1104-1105.
17. Healy B, Bibby S, Steele R, Weatherall M, Nelson H, Beasley R. Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome. J Allergy Clin Immunol 2013, 131:571-576. 10.1016/j.jaci.2012.05.058, 22920496.
18. Vaglio A, Strehl JD, Manger B, Maritati F, Alberici F, Beyer C, Rech J, Sinico RA, Bonatti F, Battistelli L, Distler JHW, Schett G, Zwerina J. IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis 2012, 71:390-393. 10.1136/ard.2011.155382, 22121132.
19. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Abingdon) 1984, 63:65-81.
20. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lightfoot RW, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ. The American college of rheumatology 1990 criteria for the classification of Churg-Strauss-Syndrome (Allergic granulomatosis and angiitis). Arthritis Rheum 1990, 1990:1094-1100.
21. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg C, McCluskey RT, Sinico RA, Rees AJ, Vanes LA, Waldherr R, Wiik A. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192. 10.1002/art.1780370206, 8129773.
22. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CGM, Merkel PA, Raspe H, Salvarani C, Scott DGI, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, Grp EVS. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009, 68:310-317. 10.1136/ard.2008.088096, 18413444.
23. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Abingdon) 1995, 75:17-28.
24. Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DGI, Witter J, Yazici H, Luqmani RA. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007, 66:605-617. 10.1136/ard.2006.062711, 2703775, 17170053.
25. Warnatz K, Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008, 74:261-271.
26. Bouldouyre M-A, Cohen P, Guillevin L. Severe bronchospasm associated with rituximab for refractory Churg-Strauss syndrome. Ann Rheum Dis 2009, 68:606-606. 10.1136/ard.2008.093773, 19286908.
27. Venhoff N, Effelsberg NM, Salzer U, Warnatz K, Peter H-H, Lebrecht D, Schlesier M, Voll RE, Thiel J. Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides. PLoS ONE 2012, 7:e37626. 10.1371/journal.pone.0037626, 3357389, 22629432.
28. Sablé-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, Blockmans D, Cordier J-F, Delaval P, Puechal X, Lauque D, Viallard J-F, Zoulim A, Guillevin L. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005, 143:632-638. 10.7326/0003-4819-143-9-200511010-00006, 16263885.
29. Sinico RA, Di Toma L, Maggiore U. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg Strauss syndrome. Arthritis Rheum 2005, 52:2926-2935. 10.1002/art.21250, 16142760.
30. Jones RB, Ferraro AJ, Chaudhry AN, Brogan P, Salama AD, Smith KGC, Savage COS, Jayne DRW. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009, 60:2156-2168. 10.1002/art.24637, 19565480.
31. Rehman MQ, Beal D, Liang Y, Noronha A, Winter H, Farraye FA, Ganley-Leal L. B cells secrete eotaxin-1 in human inflammatory bowel disease. Inflamm Bowel Dis 2013, 19:922-933. 10.1097/MIB.0b013e3182802950, 23511032.
32. Bochner BS, Gleich GJ. What targeting eosinophils has taught us about their role in diseases. J Allergy Clin Immunol 2010, 126:16-25. 10.1016/j.jaci.2010.02.026, 2902581, 20434203.